243 related articles for article (PubMed ID: 26341371)
1. Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors.
Chamberlain MC; Born D
J Neurooncol; 2015 Nov; 125(2):249-51. PubMed ID: 26341371
[TBL] [Abstract][Full Text] [Related]
2. Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.
Srebotnik-Kirbiš I; Limbäck-Stokin C
J Neurooncol; 2016 Sep; 129(3):415-422. PubMed ID: 27406587
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.
Singh VY; Chacko G; Chacko AG; Rajshekhar V
Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451
[TBL] [Abstract][Full Text] [Related]
4. Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors.
Chen H; Thomas C; Munoz FA; Alexandrescu S; Horbinski CM; Olar A; McGuone D; Camelo-Piragua S; Wang L; Pentsova E; Phillips J; Aldape K; Chen W; Iafrate AJ; Chi AS; Zagzag D; Golfinos JG; Placantonakis DG; Rosenblum M; Ohman-Strickland P; Hameed M; Snuderl M
Neuro Oncol; 2019 Sep; 21(9):1164-1174. PubMed ID: 31140557
[TBL] [Abstract][Full Text] [Related]
5. A "weighted" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p/19q codeletion in pure and mixed oligodendroglial tumors.
Senetta R; Verdun di Cantogno L; Chiusa L; Castellano I; Gugliotta P; Sapino A; Cassoni P
J Neuropathol Exp Neurol; 2013 May; 72(5):432-41. PubMed ID: 23584201
[TBL] [Abstract][Full Text] [Related]
6. Co-polysomy of chromosome 1q and 19p predicts worse prognosis in 1p/19q codeleted oligodendroglial tumors: FISH analysis of 148 consecutive cases.
Ren X; Jiang H; Cui X; Cui Y; Ma J; Jiang Z; Sui D; Lin S
Neuro Oncol; 2013 Sep; 15(9):1244-50. PubMed ID: 23861470
[TBL] [Abstract][Full Text] [Related]
7. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma.
Sathornsumetee S; Cheunsuchon P; Sangruchi T
World Neurosurg; 2016 Jul; 91():518-523.e1. PubMed ID: 26960282
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.
Gelpi E; Ambros IM; Birner P; Luegmayr A; Drlicek M; Fischer I; Kleinert R; Maier H; Huemer M; Gatterbauer B; Anton J; Rössler K; Budka H; Ambros PF; Hainfellner JA
Mod Pathol; 2003 Jul; 16(7):708-15. PubMed ID: 12861068
[TBL] [Abstract][Full Text] [Related]
9. α-Internexin in the diagnosis of oligodendroglial tumors and association with 1p/19q status.
Eigenbrod S; Roeber S; Thon N; Giese A; Krieger A; Grasbon-Frodl E; Egensperger R; Tonn JC; Kreth FW; Kretzschmar HA
J Neuropathol Exp Neurol; 2011 Nov; 70(11):970-8. PubMed ID: 22002423
[TBL] [Abstract][Full Text] [Related]
10. Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion.
Pai T; Epari S; Desai S; Wadile A; Gupta T; Goda JS; Moiyadi A; Shetty P; Kane S; Jalali R
Neurol India; 2017; 65(1):113-120. PubMed ID: 28084254
[TBL] [Abstract][Full Text] [Related]
11. Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours.
Kim JW; Park CK; Park SH; Kim YH; Han JH; Kim CY; Sohn CH; Chang KH; Jung HW
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):224-7. PubMed ID: 20587495
[TBL] [Abstract][Full Text] [Related]
12. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.
Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW
Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321
[TBL] [Abstract][Full Text] [Related]
13. Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.
Snuderl M; Eichler AF; Ligon KL; Vu QU; Silver M; Betensky RA; Ligon AH; Wen PY; Louis DN; Iafrate AJ
Clin Cancer Res; 2009 Oct; 15(20):6430-7. PubMed ID: 19808867
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.
Fallon KB; Palmer CA; Roth KA; Nabors LB; Wang W; Carpenter M; Banerjee R; Forsyth P; Rich K; Perry A
J Neuropathol Exp Neurol; 2004 Apr; 63(4):314-22. PubMed ID: 15099021
[TBL] [Abstract][Full Text] [Related]
15. The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients.
Hacisalihoglu P; Kucukodaci Z; Gundogdu G; Bilgic B
Turk Neurosurg; 2017; 27(5):682-689. PubMed ID: 27651340
[TBL] [Abstract][Full Text] [Related]
16. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.
Li YX; Shi Z; Aibaidula A; Chen H; Tang Q; Li KK; Chung NY; Chan DT; Poon WS; Mao Y; Wu J; Zhou L; Chan AK; Ng HK
Oncotarget; 2016 Oct; 7(40):64615-64630. PubMed ID: 27556304
[TBL] [Abstract][Full Text] [Related]
17. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A;
Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167
[TBL] [Abstract][Full Text] [Related]
18. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography.
Iwadate Y; Shinozaki N; Matsutani T; Uchino Y; Saeki N
J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1016-21. PubMed ID: 26848169
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH.
Talagas M; Marcorelles P; Uguen A; Redon S; Quintin-Roué I; Costa S; Férec C; Morel F; Hieu PD; De Braekeleer M
J Neurooncol; 2012 Sep; 109(2):405-13. PubMed ID: 22825724
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.
Kouwenhoven MC; Gorlia T; Kros JM; Ibdaih A; Brandes AA; Bromberg JE; Mokhtari K; van Duinen SG; Teepen JL; Wesseling P; Vandenbos F; Grisold W; Sipos L; Mirimanoff R; Vecht CJ; Allgeier A; Lacombe D; van den Bent MJ
Neuro Oncol; 2009 Dec; 11(6):737-46. PubMed ID: 19224764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]